March 29, 2022
Enzo Biochem Appoints David Bench and Kara Cannon to New Executive Management Positions
NEW YORK, NY, March 28, 2022 (GLOBE NEWSWIRE) — Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading…
Pharmaceuticals, Biotechnology and Life Sciences
Author: GlobeNewswire
March 29, 2022
DICE Therapeutics Expands Management Team and Board of Directors
Mary Riley, J.D., appointed as general counselLisa Bowers, MHSA, and Mittie Doyle, M.D., FACR, join board of directors SOUTH SAN…
March 29, 2022
Kinnate Biopharma Inc. Reports Full Year 2021 Financial Results and Provides Operational Updates
Initiated Phase 1 clinical trial for KIN-3248 in the first quarter of 2022 Initial monotherapy data from the ongoing KN-8701…
March 29, 2022
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results
-Initial Data from Phase 1/2 Study of Oral Fadraciclib in Solid Tumors Expected in First Half of 2022 – -Cash…
March 29, 2022
Eyenovia Reports Fourth Quarter and Full Year 2021 Financial Results
Successfully completed Type A meeting with FDA and anticipates MydCombi™ NDA resubmission in Q3 2022 Enrolled first patient in the…
March 29, 2022
Synthetic Biologics Announces Journal for ImmunoTherapy of Cancer Publication of Phase 1 Trial of Intravenous VCN-01 Oncolytic Adenovirus in Patients With Advanced Solid Tumors
-Data support VCN-01 acceptable safety profile with encouraging biological and clinical activity, and identify recommended Phase 2 dose (RP2D)- -Publication…
March 29, 2022
Ayala Pharmaceuticals Reports Full-Year 2021 Financial Results and Provides Corporate Update
– Part A of AL102 RINGSIDE study fully enrolled; interim data expected mid-2022 –REHOVOT, Israel and WILMINGTON, Del., March 28, 2022…
March 29, 2022
Acumen Pharmaceuticals Reports Financial Results for Full Year Ended December 31, 2021 and Business Highlights
Acumen is progressing ACU193, the first monoclonal antibody designed to selectively target toxic amyloid-beta oligomers (AβOs) to enter clinical testing…
March 27, 2022
Sanofi: Information concerning the total number of voting rights and shares – February 2022
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code…
March 27, 2022
New GEM-3 Phase 3 Results for B-VEC Presented at 2022 American Academy of Dermatology Annual Meeting
PITTSBURGH, March 26, 2022 (GLOBE NEWSWIRE) — Krystal Biotech, Inc., (“Krystal Biotech”) (NASDAQ: KRYS), the leader in redosable gene therapies for…